Oric Pharmaceuticals, Inc. (ORIC) Capital expenditures 2018–2025
Oric Pharmaceuticals, Inc. (ORIC) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$712,000FY2025 · since FY2018: $525,000 → $712,000
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $712,000 | -40.1% |
| FY2024 | $1.2M | +39.9% |
| FY2023 | $849,000 | -59.1% |
| FY2022 | $2.1M | +121.3% |
| FY2021 | $939,000 | +40.8% |
| FY2020 | $667,000 | -13.2% |
| FY2019 | $768,000 | +46.3% |
| FY2018 | $525,000 | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice